Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market
3/28/2008 9:13:13 AM
PALM BEACH GARDENS, FL--(Marketwire - March 27, 2008) -
Pegasus Pharmaceuticals (PINKSHEETS: PGUZ) today announced that it has filed for patents for its innovative biological product, MOLD GONE™. Pegasus is engaged in the research, development and marketing of anti-microbial compositions and systems for killing, inhibiting and growth prevention of fungal matter such as live cells, spores and mycotoxins associated with molds.